Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference325 articles.
1. Design, synthesis and biological evaluation of quinazolin-4-one based hydroxamic acids as dual PI3K/HDAC inhibitors;Thakur;J. Med. Chem.,2020
2. Hallmarks of cancer: the next generation;Hanahan;Cell,2011
3. Why is cancer drug discovery so difficult?;Kamb;Nat. Rev. Drug Discov.,2007
4. Targeting tumour-supportive cellular machineries in anticancer drug development;Dobbelstein;Nat. Rev. Drug Discov.,2014
5. Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity;Ibrahim;Bioorg. Chem.,2020
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. HDAC/NAMPT dual inhibitors overcome initial drug-resistance in p53-null leukemia cells;European Journal of Medicinal Chemistry;2024-02
2. Dual-targeting compounds possessing enhanced anticancer activity via microtubule disruption and histone deacetylase inhibition;European Journal of Medicinal Chemistry;2024-02
3. Multitargeting HDAC Inhibitors Containing a RAS/RAF Protein Interfering Unit;Journal of Medicinal Chemistry;2024-01-23
4. MHY446 induces apoptosis via reactive oxygen species-mediated endoplasmic reticulum stress in HCT116 human colorectal cancer cells;Journal of Chemotherapy;2023-12-06
5. Design, synthesis, and biological evaluation of novel HDAC/CD13 dual inhibitors for the treatment of cancer;European Journal of Medicinal Chemistry;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3